Renaissance Technologies - CYCLACEL PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CYCLACEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$66
-34.7%
185,500
+8.7%
0.00%
Q2 2023$101
+4.1%
170,700
+0.6%
0.00%
Q1 2023$97
-13.4%
169,700
+0.8%
0.00%
Q4 2022$112
-100.0%
168,400
+0.5%
0.00%
Q3 2022$245,000
+260.3%
167,600
+166.0%
0.00%
Q2 2022$68,000
-91.5%
63,000
-63.3%
0.00%
-100.0%
Q2 2020$798,000171,6770.00%
Other shareholders
CYCLACEL PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 388,632$2,048,0001.16%
Tri Locum Partners LP 522,943$2,756,0001.10%
Sio Capital Management, LLC 422,598$2,227,0000.71%
Affinity Asset Advisors, LLC 400,000$2,108,0000.53%
SPHERA FUNDS MANAGEMENT LTD. 508,322$2,679,0000.22%
Ikarian Capital, LLC 99,422$524,0000.04%
PURA VIDA INVESTMENTS, LLC 105,141$554,0000.02%
Virtu Financial LLC 20,029$106,0000.01%
NEXT Financial Group, Inc 14,752$77,0000.01%
Schonfeld Strategic Advisors LLC 103,925$548,0000.01%
View complete list of CYCLACEL PHARMACEUTICALS INC shareholders